Biocryst stock news
WebApr 6, 2024 · Financial Performance. In 2024, BCRX's revenue was $270.83 million, an increase of 72.31% compared to the previous year's $157.17 million. Losses were -$247.12 million, 34.3% more than in 2024. Financial Statements. WebApr 8, 2024 · RBC Capital analyst Brian Abrahams maintained a Hold rating on BioCryst ( BCRX – Research Report) on April 6 and set a price target of $9.00. The company’s shares closed last Thursday at $8.68 ...
Biocryst stock news
Did you know?
WebApr 12, 2024 · BioCryst to Present at Upcoming Investor Conferences. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst … WebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of the company's stock in a transaction that occurred on Wednesday, February 1st. The stock was sold at an average price of $10.38, for a total transaction of $1,038,000.00. ... Hedge funds and other institutional investors own 79.05% of the …
WebApr 4, 2024 · RESEARCH TRIANGLE PARK, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired employees stock options to purchase an aggregate of 124,300 shares, and restricted stock units (RSUs) … WebSep 13, 2024 · BioCryst has beat first- and second-quarter Wall Street sales estimates by more than 75%. There is currently a short position of 20-plus million shares in a stock that has an average daily trading ...
WebApr 11, 2024 · BioCryst's ORLADEYO is off to a great, great start in HAE, BCRX withdrew their $200mn offering and a few months later, Royalty Pharma and OMERS Capital Market together purchased $350mn of ... WebApr 12, 2024 · April 12, 2024 - 7:00 am. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today …
Web12/31/2024: WOODLINE PARTNERS LP Bought 2.1 Million shares of BioCryst Pharmaceuticals ...: 12/31/2024: JANUS HENDERSON INVESTORS US LLC Bought 2.0 Million shares of BioCryst Pharmaceuticals ...
WebApr 6, 2024 · SA News Fri, Mar. 18, 2024 3 Comments BioCryst executive sells 20K company shares in first insider selling since May 2024 SA News Thu, Mar. 10, 2024 12 Comments signs of partial acl tearWebDec 15, 2024 · RESEARCH TRIANGLE PARK, N.C., Dec. 15, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, based on new competitive data recently presented at the American ... signs of parasite infectionWebApr 6, 2024 · finance.yahoo.com - February 21 at 9:36 AM. Why BioCryst Pharmaceuticals Stock Is Sliding Today. benzinga.com - February 21 at 9:36 AM. BioCryst Pharmaceuticals Non-GAAP EPS of -$0.38 misses by $0.18, revenue of $79.5M beats by $5.32M. msn.com - February 21 at 9:36 AM. therapie extrasystolenWebNov 1, 2024 · Mirae Asset Global Investments Co. Ltd. Makes New Investment in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Defense World 10/25/2024 therapie externe alcoholWebBioCryst Pharmaceuticals Inc. shares surged more than 6% premarket on the news that it has won a $35 million, five-year contract from the Centers for Disease Control and … signs of parkinson\\u0027sWebFeb 23, 2024 · BioCryst (BCRX) delivered earnings and revenue surprises of -29.03% and 2.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? therapie facialispareseWebApr 8, 2024 · What happened. Shares of BioCryst Pharmaceuticals ( BCRX) were crashing 32.9% lower as of 10:38 a.m. ET on Friday. The steep decline came after the company … therapiefahrrad